The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy
Cancers - Switzerland
doi 10.3390/cancers11121894
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2019
Authors
Publisher
MDPI AG